Faculty & Staff at TUC

Jeremiah Duby

College: COP

Department: Clinical Sciences

Title: Adjunct Associate Professor

Phone: (707) 638-5932

Fax: (707) 638-5959

E-Mail: jeremiah.duby@tu.edu

Office: Administration & Faculty 2, Rm. 109

Jeremiah J. Duby, Pharm.D., BCPS is Senior Critical Care Pharmacist and Specialty Critical Care Residency Program Director for the U.C. Davis Medical Center (UCDMC).  He serves as Assistant Clinical Professor for Touro University College of Pharmacy, UCSF School of Pharmacy, and U.C. Davis School of Medicine. His clinical practice is in patient care with Trauma Surgery, Burn Surgery, Medical ICU, and Parenteral Nutrition services. These activities serve as inspiration for his roles in policy and protocol development and research. Additionally, he provides didactic lectures for TU and UCSF students on acute care topics that include clinical pharmacokinetics, fluid/electrolyte abnormalities, acute pain, sepsis/septic shock, acid-base disorders, skin-soft tissue infections, pneumonia, and clinical toxicology.  Current research interests range from alcohol withdrawal syndrome to diabetic ketoacidosis to acute arrhythmias.

Dr. Duby graduated from Washington State University (2003) and then a completed pharmacy practice residency (PGY-1, 2004, William L. Fritz, MS, FASHP) and critical care residency (PGY-2, 2005, Brian L. Erstad, Pharm.D., FCCM) with an emphasis in infectious diseases and nutrition at the University of Arizona Medical Center (UAMC).  He first served as an infectious diseases pharmacist for Kaiser Permanente (2005 – 2007), helping pilot and establish a successful antimicrobial stewardship service with Stephen M. Parodi, M.D., which later became as model of patient care for the region.

Institution Degree Field of Study Obtained
University of Arizona  PGY-2 Residency Certificate Specialty Residency: Critical Care with emphasis in Infectious Disease and Nutrition 06.30.05
University of Arizona  PGY-1 Residency Certificate  General Pharmacy Practice Residency 06.30.04
Washington State University Doctor of Pharmacy   05.09.03

PHRM 612 — Clinical Sciences III (5 credits, 95 – 105 students).

Lecturer and Case Facilitator: Fall Semester 2013, Touro University College of Pharmacy.

■      CNS Infections (August 26, 2013)

 

PHRM 604 — Clinical Sciences I (5 credits, 95 – 105 students).

Lecturer and Case Facilitator: Fall Semester 2012, Touro University College of Pharmacy.

■      Antimicrobial Selection (October 23, 2013)

 

PHRM 608 — Clinical Sciences II (5 credits, 95 – 105 students).

Lecturer and Case Facilitator: Spring Semester 2011, Touro University College of Pharmacy.

■      Fluids and Electrolyte Disorders (March 1, 2013)

■      Acid-Base Disorders (March 6, 2013)

■      Skin Soft Tissue Infections and Surgical Site Infections (January 3, 2013)

 

PHRM 612 — Clinical Sciences III (5 credits, 95 – 105 students).

Lecturer and Case Facilitator: Fall Semester 2011, Touro University College of Pharmacy.

■      Pain Management (November 6, 2012)

■      CNS Infections (August 27, 2012)

 

PHRM 614 — Pharmaceutical Sciences IV (5 credits, 90 – 100 students)

Lecturer and Case Facilitator: Spring Semester 2011, Touro University College of Pharmacy.

■      Clinical Toxicology (March 11, 2013)

■      Clinical Pharmacokinetics: Aminoglycosides (February 25, 2013)

■      Clinical Pharmacokinetics: Vancomycin (February 21, 2013)

 

PHRM 616 — Clinical Sciences IV (5 credits, 95 – 105 students). 

Course Coordinator and Lecturer: Spring Semester 2011, Touro University College of Pharmacy.

■      Urinary Tract Infections and Prostatitis (January 7, 2013)

■      Lower Respiratory Tract Infections-II: Nosocomial and Aspiration pneumonia (March 7, 2012)

■      Intra-abdominal Infections (March 4, 2013)

■      Sepsis & Septic Shock (March 12, 2013)

 

PHRM 604 — Clinical Sciences I (5 credits, 95 – 105 students).

Lecturer and Case Facilitator: Fall Semester 2012, Touro University College of Pharmacy.

■      Antimicrobial Selection (October 10, 2012)

 

PHRM 608 — Clinical Sciences II (5 credits, 95 – 105 students).

Lecturer and Case Facilitator: Spring Semester 2011, Touro University College of Pharmacy.

■      Fluids and Electrolyte Disorders (March 11, 2012)

■      Acid-Base Disorders (March 06, 2012)

■      Skin Soft Tissue Infections and Surgical Site Infections (January 11, 2012)

 

PHRM 612 — Clinical Sciences III (5 credits, 95 – 105 students).

Lecturer and Case Facilitator: Fall Semester 2011, Touro University College of Pharmacy.

■      Pain Management (September 10, 2011)

■      CNS Infections (August 30, 2011)

 

PHRM 614 — Pharmaceutical Sciences IV (5 credits, 90 – 100 students)

Lecturer and Case Facilitator: Spring Semester 2011, Touro University College of Pharmacy.

■      Clinical Pharmacokinetics: Vancomycin (February 21, 2012)

■      Clinical Pharmacokinetics: Aminoglycosides (February 27, 2012)

 

PHRM 616 — Clinical Sciences IV (5 credits, 95 – 105 students). 

Course Coordinator and Lecturer: Spring Semester 2011, Touro University College of Pharmacy.

■      Urinary Tract Infections and Prostatitis (January 9, 2012)

■      Lower Respiratory Tract Infections-II: Nosocomial and Aspiration pneumonia (March 5, 2012)

■      Intra-abdominal Infections (March 12, 2012)

■      Sepsis & Septic Shock (March 12, 2012)

 

PHRM 608 — Clinical Sciences II (5 credits, 95 – 105 students).

Lecturer and Case Facilitator: Spring Semester 2011, Touro University College of Pharmacy.

■      Acid-Base Disorders (March 14, 2011)

■      Fluids and Electrolyte Disorders (March 9, 2011)

■      Skin Soft Tissue Infections and Surgical Site Infections (January 12, 2011)

 

PHRM 616 — Clinical Sciences IV (5 credits, 95 – 105 students). 

Course Coordinator and Lecturer: Spring Semester 2011, Touro University College of Pharmacy.

■      Intra-Abdominal Infections (March 12, 2011)

■      Sepsis and Septic Shock (March 9, 2011)

■      Nosocomial and Aspiration PNA (March 5, 2011)

■      Community-Acquired Pneumonia and Acute Bronchitis (February 23, 2011)

■      Urinary Tract Infections and Prostatitis (January 13, 2011)

 

PHRM 614 — Pharmaceutical Sciences IV (5 credits, 90 – 100 students)

Lecturer and Case Facilitator: Spring Semester 2011, Touro University College of Pharmacy.

■      Clinical Pharmacokinetics: Vancomycin (January 24, 2011)

■      Clinical Pharmacokinetics: Aminoglycosides (January 26, 2011)

 

PHRM 612 — Clinical Sciences III (5 credits, 95 – 105 students).

Lecturer and Case Facilitator: Fall Semester 2010, Touro University College of Pharmacy.

■      Pain Management (September 2, 2010)

■      CNS Infections (November 9, 2010)

 

PHRM 604 — Clinical Sciences I (5 credits, 95 – 105 students).

Lecturer and Case Facilitator: Fall Semester 2010, Touro University College of Pharmacy.

■      Antimicrobial Selection (November 26, 2010)

 

PHRM 702 — Rotational Callbacks

Lecturer: Spring 2010, Touro University College of Pharmacy.

■      Case-Based PK Review: Vancomycin and Aminoglycosides (February 9, 2010)

 

PHRM 616 — Clinical Sciences IV (5 credits, 95 – 105 students). 

Course Coordinator and Lecturer: Spring 2010, Touro University College of Pharmacy.

■      Sepsis and Septic Shock (March 16, 2010)

■      Lower Respiratory Tract Infections (February 16, 2010)

■      Urinary Tract Infections and Prostatitis (January 14, 2010)

 

PHRM 614 — Pharmaceutical Sciences IV (5 credits, 90 – 100 students)

Lecturer and Case Facilitator: Spring Semester 2010, Touro University College of Pharmacy.

■      Clinical Pharmacokinetics: Vancomycin (February 3, 2010)

■      Clinical Pharmacokinetics: Aminoglycosides (January 4, 2010)

 

PHRM 608 — Clinical Sciences II (5 credits, 95 – 105 students).

Lecturer and Case Facilitator: Spring Semester 2010, Touro University College of Pharmacy.

■      Fluids and Electrolytes (March 4, 2010)

■      Acid-Base Disorders (March 9, 2010)

■      Gastrointestinal Infections (February 16, 2010)

■      Skin/Soft Tissue and Surgical Site Infections (January 14, 2010)

 

PHRM 612 — Clinical Sciences III (5 credits, 95 – 105 students).

Lecturer and Case Facilitator: Fall Semester 2009, Touro University College of Pharmacy.

■      CNS Infections (September 10, 2009)

■      Pain Management (September 3, 2009)

 

PHRM 604 — Clinical Sciences I (5 credits, 95 – 105 students).

Lecturer and Case Facilitator: Fall Semester 2009, Touro University College of Pharmacy.

■      Antimicrobial Selection (December 6, 2009)

 

PHRM 616 — Clinical Sciences IV (5 credits, 90 – 100 students). 

Course Coordinator and Lecturer: Spring 2009, Touro University College of Pharmacy.

■      Sepsis and Septic Shock (March 12, 2009)

■      Bone and Joint Infections (March 10, 2009)

■      Lower Respiratory Tract Infections (February 17, 2009)

■      Sexually Transmitted Diseases (January 22, 2009)

■      Urinary Tract Infections and Prostatitis (January 20, 2009)

 

PHRM 614 — Pharmaceutical Sciences IV (5 credits, 90 – 100 students)

Lecturer and Case Facilitator: Spring Semester 2009, Touro University College of Pharmacy.

■      Clinical Pharmacokinetics: Aminoglycosides & Vancomycin (February 5, 2009)

■      Clinical Pharmacokinetics: Aminoglycosides & Vancomycin (January 27, 2009)

 

PHRM 608 — Clinical Sciences II (5 credits, 95 – 105 students).

Lecturer and Case Facilitator: Spring Semester 2009, Touro University College of Pharmacy.

■      Fluid and Electrolyte Disorders (March 10, 2009)

■      Acid-Base Disorders (March 12, 2009)

■      Gastrointestinal Infections (February 17, 2009)

■      Skin/Soft Tissue and Surgical Site Infections (January 15, 2009)

 

PHRM 612 — Clinical Sciences III (5 credits, 90 – 105 students).

Lecturer and Case Facilitator: Fall Semester 2008, Touro University College of Pharmacy.

■      Upper Respiratory Infections (August 19, 2008)

■      CNS Infections (August 28, 2008)

■      Pain Management (September 2, 2008)

 

PHRM 604 — Clinical Sciences I (5 credits, 90 – 105 students).

Lecturer and Case Facilitator: Fall Semester 2008, Touro University College of Pharmacy.

■      Antimicrobial Selection (December 9, 2008)

 

PHRM 616 — Clinical Sciences IV (5 credits, 90 – 105 students). 

Course Coordinator and Lecturer: Spring 2008, Touro University College of Pharmacy.

■      Pharmacokinetic Concepts and Applications (April 7, 2008)

■      Sepsis and Septic Shock (April 3, 2008)

■      Bone and Joint Infections (March 25, 2008)

■      Community-Acquired Pneumonia and Acute Bronchitis (March 4, 2008)

■      Sexually Transmitted Diseases (January 22, 2008)

■      Urinary Tract Infections and Prostatitis (January 17, 2008)

 

PHRM 608 — Clinical Sciences II (5 credits, 90 – 105 students).

Lecturer and Case Facilitator: Spring Semester 2008, Touro University College of Pharmacy.

■      Gastrointestinal Infections (February 14, 2008)

■      Skin/Soft Tissue and Surgical Site Infections (January 15, 2008)

 

PHRM 702 — Rotational Callbacks

Lecturer: Fall 2009, Touro University College of Pharmacy.

■      Anemia of Critical Illness (August 28, 2008)

Firestone R, Duby JJ, Pandya K, Parker P.  Effect of a conservative-correction DKA protocol on clinical outcomes in hospitalized patients.  43rd Critical Care Congress.  San Francisco, CA: Display and Oral Presentation.  

Smith CA, Schermer CR, Duby JJ, Utter G, Scherer LA.  Cost Minimization Analysis of Fluid Resuscitation of Critically Injured Trauma Patients.  AJHP.  2013; (pending press).

Koo AY, Duby JJ. Angela Y Koo. Exploring the Diversity of Discourse and Voices in the Pharmacy Community: Authors, Speakers, and Terms.  American Society of Health-System Pharmacist (ASHP) Midyear Clinical Meeting.  Orlando, FL.  December 8 – 12, 2013. 

Evans CH, Duby JJ, Berry AJ, Schermer CR, Cocanour CS.  Enteral albuterol decreases the need for chronotropic agents in patients with cervical spinal cord injury (CSCI) induced bradycardia.  72nd Annual Meeting, American Association for the Surgery of Trauma and Clinical Congress of Acute Care Surgery.  San Francisco, CA: Podium Presentation.  September 21, 2013.

Donnelley MA, Duby JJ, Cocanour CS.  Safety and Efficacy of Fidaxomicin in Patients With Clostridium Difficile Infection. Clinical Medicine Insights: Therapeutics. 2013; 5: 75 – 79.

Nagle EL, Dager WE, Duby JJ, Roberts AJ, Kenny LE, Murthy MS, Pretzlaff RK.  Bivalirudin in pediatric patients maintained on extracorporeal life support.  Pediatr Crit Care Med. 2013 May;14(4):e182-8. doi: 10.1097/PCC.0b013e31827200b6.

Nagle E, Murthy M, Medina M, Floyd K, Love, D, Duby JJ.  Nursing clinical discretion and decisions in the provision of pharmacotherapy in the intensive care unit.  [abstract/poster].  42nd Critical Care Congress.  San Juan, Puerto Rico: Display and Professor Walk Rounds.  January 20, 2012.

Bajorek S, Duby JJ, Heint S, Heintz H, Cocanour CS.  Risk factors, prevalence, course, and complications of atrial fibrillation in critically ill trauma patients.  42nd Critical Care Congress.  San Juan, Puerto Rico: Display and Professor Walk Rounds.  January 20, 2013.

Murthy M, Nagle E, Parker P, Duby JJ.  Dose response effect of rescue intravenous dextrose for hypoglycemia in critically ill patients.  42nd Critical Care Congress.  San Juan, Puerto Rico: Display and Oral Presentation.  January 20, 2013.

Berry A, Cocanour CS, Duby JJ.  Management of Alcohol Withdrawal Syndrome (AWS) that Complicates the Course of Critically Ill Patients. [abstract/poster].  41st Critical Care Congress.  Houston, TX: Display and Professor Walk Rounds.  February 7, 2012.

Murthy M, Nagle E, Duby JJ, Roach D, Parker P.  Dose Response to Rescue Intravenous Dextrose Administration following Hypoglycemic Events with an Insulin Infusion Protocol in Critically Ill Burn Patients.  [abstract/poster].  41st Critical Care Congress.  Houston, TX: Display and Professor Walk Rounds.  February 7, 2012.

Nagle E, Pretzlaff R, Duby JJ, Roberts JA, Murthy M, Dager WE.  A Case Series Describing the Use of Bivalirudin in Pediatric Patients Maintained on Extracorporeal Life Support.  [abstract/poster].  41st Critical Care Congress.  Houston, TX.  February 4, 2012.

VonMuenster SJ, Cocanour CS, Duby JJ.  Prevalence and Course of Atrial Fibrillation (AF) in Critically Ill Trauma Patients.  [abstract/poster].  Annual Meeting.  Western Surgical Association.  Tucson, AZ: Podium Presentation, November 13, 2011.

Smith CA, Schermer CR, Duby JJ, Utter G, Scherer LA.  Cost Minimization Analysis of Fluid Resuscitation of Critically Injured Trauma PatientsAJHP.  2013; (pending press).

Nagle EL, Dager WE, Duby JJ, Roberts AJ, Kenny LE, Murthy MS, Pretzlaff RK.  Bivalirudin in pediatric patients maintained on extracorporeal life supportPediatr Crit Care Med. 2013 May;14(4):e182-8. doi: 10.1097/PCC.0b013e31827200b6.

Donnelley MA, Duby JJ, Cocanour CS.  Safety and Efficacy of Fidaxomicin in Patients With Clostridium Difficile Infection. Clinical Medicine Insights: Therapeutics. 2013; 5: 75 – 79.

Matzke GR, Duby JJ.  Vancomycin.  In: Murphy JE.  Clinical Pharmacokinetics.  5th ed.  Bethesda, MD: American Society of Health-System Pharmacists; 2011.

Duby JJ, Heintz BH.  Clostridium difficile Associated Diarrhea.  In: Katz MD, Matthias KR, Chisholm-Burns MA.  Pharmacotherapy Principles and Practice Study Guide: A Case-Based Care Plan Approach.  New York, NY: McGraw-Hill; 2010: 327 - 329.

Kopp B, Mrsan M, Erstad BL, Duby JJ. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. American Journal of Health-System Pharmacy. 2007; 64: 2483 – 2487.

Duby JJ, Erstad BL, Abarca J, Camamo JM, Huckleberry Y, Bramblett SN. Impact of delayed initiation of erythropoietin in critically ill patients. Blood Disorders. 2007; 7:1.


Poster: Survey of nurse administration of phenytoin through enteral feeding tubes concomitantly with enteral nutrition. Poster: ASHP 2007 Summer Meeting and Exhibition. San Francisco, CA. June 25, 2007.

Patanwala AE, Duby JJ, Waters D, Erstad BL. Opioid Conversion in Acute Care. Annals of Pharmacotherapy. 2007; 41(2): 255 – 266.

Poster: Cost-Benefit of Epoetin alfa in the Critically Ill Patient: Published Trials versus Practice. ASHP 2006 Summer Meeting and Exhibition. Orlando, FA. June 28, 2006.

Contributor/Reviewer: Recommendations for Safe Use of Insulin in Hospitals: A Joint Project of the American Society of Health-System Pharmacists and the Hospital and Health-System Association of Pennsylvania.

Duby JJ, Campbell RK. Treatment of Painful Diabetic Neuropathy. U.S. Pharmacist. 2004; 29(11).

Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA. Diabetic Neuropathy: An Intensive Review. American Journal of Health-System Pharmacy. 2004; 61: 160 - 173.

U.C Davis School of Medicine

UCSF School of Pharmacy

Endocrine Specialty Award for critical care research.  Society of Critical Care Medicine.  January 12, 2014                              

Apple for Excellence in Teaching Award.  UCSF School of Pharmacy.  March 2011.                                                   

Employer Title From - To
U.C. Davis Medical Center Senior Critical Care Pharmacist 11.18.07
Kaiser Permanente Clinical Pharmacist: Infectious Disease and Critical Care 09.29.05 - 11.15.07
Last Updated: 3/15/16